Literature DB >> 19473071

Percutaneous nephrolithotomy: factors associated with fever after the first postoperative day and systemic inflammatory response syndrome.

Ronald O P Draga1, Esther T Kok, Marique R Sorel, Ruud J L H Bosch, Tycho M T W Lock.   

Abstract

OBJECTIVE: Fever after the first postoperative day (POD1) after percutaneous nephrolithotomy (PCNL) is most likely caused by an infection that increases hospital stay and healthcare costs. The aim of this study was to find factors associated with fever after POD1 and systemic inflammatory response syndrome (SIRS). PATIENTS AND METHODS: Ninety patients underwent 117 PCNLs. Patient characteristics, stone burden, and pre- and postoperative treatments were analyzed for association with fever (temperature >or=38 degrees C) and SIRS using univariate analysis.
RESULTS: In 35% of the patients with fever (temperature >or=38 degrees C), fever was present after POD1. Twelve patients developed signs of SIRS (11.2%). In univariate analysis, significant association was observed between fever after POD1 and previous ipsilateral PCNL (p = 0.022, odds ratio OR = 3.1), and between SIRS and paraplegia (p = 0.005, OR = 10.7) and caliceal stones (p = 0.03, OR = 4.8).
CONCLUSIONS: Previous ipsilateral PCNL increases the risk of fever after POD1. Paraplegic patients are at risk for developing SIRS after PCNL.

Entities:  

Mesh:

Year:  2009        PMID: 19473071     DOI: 10.1089/end.2009.0041

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  36 in total

Review 1.  Risk factors for sepsis after percutaneous renal stone surgery.

Authors:  Evgeniy I Kreydin; Brian H Eisner
Journal:  Nat Rev Urol       Date:  2013-09-03       Impact factor: 14.432

2.  Positive stone culture is associated with a higher rate of sepsis after endourological procedures.

Authors:  Jairam R Eswara; Ahmad Shariftabrizi; Ahmad Sharif-Tabrizi; Dianne Sacco
Journal:  Urolithiasis       Date:  2013-06-13       Impact factor: 3.436

3.  High carbonate level of apatite in kidney stones implies infection, but is it predictive?

Authors:  Kate M Englert; James A McAteer; James E Lingeman; James C Williams
Journal:  Urolithiasis       Date:  2013-07-24       Impact factor: 3.436

4.  The Role of Antibiotic Prophylaxis in Percutaneous Nephrolithotomy.

Authors:  Win Shun Lai; Dean Assimos
Journal:  Rev Urol       Date:  2016

5.  Risk factors for postoperative infectious complications following percutaneous nephrolithotomy: a prospective clinical study.

Authors:  Omer Koras; Ibrahim Halil Bozkurt; Tarik Yonguc; Tansu Degirmenci; Burak Arslan; Bulent Gunlusoy; Ozgu Aydogdu; Suleyman Minareci
Journal:  Urolithiasis       Date:  2014-10-01       Impact factor: 3.436

Review 6.  Antibiotic use and the prevention and management of infectious complications in stone disease.

Authors:  Daniel A Wollin; Adrian D Joyce; Mantu Gupta; Michael Y C Wong; Pilar Laguna; Stavros Gravas; Jorge Gutierrez; Luigi Cormio; Kunjie Wang; Glenn M Preminger
Journal:  World J Urol       Date:  2017-02-03       Impact factor: 4.226

Review 7.  Renal struvite stones--pathogenesis, microbiology, and management strategies.

Authors:  Ryan Flannigan; Wai Ho Choy; Ben Chew; Dirk Lange
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

8.  Predictive risk factors for systemic inflammatory response syndrome following ureteroscopic laser lithotripsy.

Authors:  Yusuke Uchida; Ryoji Takazawa; Sachi Kitayama; Toshihiko Tsujii
Journal:  Urolithiasis       Date:  2017-07-10       Impact factor: 3.436

9.  Risk factors for systemic inflammatory response syndrome following percutaneous nephrolithotomy.

Authors:  Tunc Erdil; Yakup Bostanci; Ender Ozden; Fatih Atac; Yarkin Kamil Yakupoglu; Ali Faik Yilmaz; Saban Sarikaya
Journal:  Urolithiasis       Date:  2013-05-28       Impact factor: 3.436

10.  The effect of delayed percutaneous nephrolithotomy on the risk of bacteremia and sepsis in patients with neuromuscular disorders.

Authors:  Jairam R Eswara; Hang Lee; Stephen P Dretler; Dianne Sacco
Journal:  World J Urol       Date:  2013-02-27       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.